BioMarin Pharma Announces FDA Approval Of ROCTAVIAN Gene Therapy
30/6 07:22
(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) announced the FDA approved ROCTAVIAN gene therapy for the treatment of adults with severe hemophilia A without antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. The company noted that the one-time, si...